Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Multivalent DTP-POLIO vaccines

An immunization composition, a technique for poliomyelitis, applied in the field of multivalent vaccines administered in pediatrics

Inactive Publication Date: 2008-11-26
CONNAUGHT LAB
View PDF10 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Currently available commercial combination vaccines may not contain appropriate formulations of the appropriate antigens in the appropriate immunogenic form to achieve the required level of efficacy in pertussis-susceptible populations

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Multivalent DTP-POLIO vaccines
  • Multivalent DTP-POLIO vaccines
  • Multivalent DTP-POLIO vaccines

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

Embodiment 1

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
pore sizeaaaaaaaaaa
Login to View More

Abstract

A multi-component vaccine composition is described comprising acellular pertussis vaccine components, diphtheria toxoid, tetanus toxoid and inactivated poliovirus. The composition also may contain a conjugate of a capsular polysaccharide of Haemophilus influenzae type b and tetanus toxoid or diphteria toxoid, which may be reconstituted from a lyophilized state by the other components of the vaccine. The administration of the multiple component vaccine results in no diminution in the immunogenicity of any component as a result of interference by other components of the vaccine.

Description

This application is a divisional application of an invention patent application with an application date of July 2, 1997, an application number of 97197609.0, and an invention title of "multivalent DTP-POLIO vaccine". field of invention The present invention relates to multivalent vaccines, in particular multivalent vaccines for pediatric administration. Referenced related applications This application is a continuation-in-part of co-pending U.S. Patent Application No. 08 / 501,743 filed July 12, 1995, which itself is a co-pending U.S. Patent Application No. filed May 4, 1995. Part of 08 / 433,646 continued application. Background of the invention Pertussis is a severe, highly contagious upper respiratory tract infection caused by the bacterium Bordetella pertussis (B. pertussis). The World Health Organization estimates that there are 60 million cases of pertussis each year, resulting in 500,000 to 1 million deaths (Ref. 1. Throughout this specification, various references...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K39/295A61P31/04A61P31/14A61K31/00A61K39/05A61K39/08A61K39/10A61K39/102A61K39/116A61K39/13A61P31/00A61P31/12
CPCA61K2039/70C12N2760/16234C12N2770/32634A61K39/08A61K39/12A61K39/102A61K2039/55505A61K2039/5252A61K39/0016A61K39/099A61K39/05A61K2039/55A61K39/295A61P11/00A61P31/00A61P31/04A61P31/12A61P31/14A61P31/16A61P37/04Y02A50/30
Inventor R·E·F·法希姆L·U·L·潭L·巴雷托J·蒂普哈旺G·E·D·杰克森
Owner CONNAUGHT LAB
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products